Problems of Virology

SCImago Journal & Country Rank
SciteSore by SCOPUS

International peer-reviewed scientific and practical journal "Problems of Virology" (Russian title Voprosy virusologii”, ISSN (Print) 0507-4088, ISSN (Online) 2411-2097) acquaints readers with the achievements of Russian and international virology, publishes articles on the study of viruses and viral diseases of humans, animals and plants. A prominent place in the journal is given to the publication of the results of experimental studies on various fields in fundamental and applied virology.

The journal publishes materials that contribute to the implementation in practice of the achievements of virological science in eliminating and reducing the prevalence of infectious diseases, as well as its diagnosis, prevention and treatment.

The review articles summarize the latest advances in virology. In order to attract the attention of virologists to the most actual issues requiring further study, the journal publishes editorial notes and book reviews. The reader will find in the journal a description of new research methods, new equipment, diagnostic and treatment tools.

The journal is intended for virologists (medical and veterinary), epidemiologists, parasitologists, pharmacologists, biochemists and other specialists.

«Problems of Virology» is an open access journal that does not charge for the publication of scientific articles.

The journal is presented in SCOPUS database (Q4).

The journal is included in the recommended by the Higher Attestation Commission "List of peer-reviewed scientific publications in which the main scientific results of dissertations for the doctoral degree (PhD), for the degree of doctor of science should be published" (in accordance with paragraph 5 of the Rules for the formation of the List, as part of the international abstract database and citation systems Scopus) in the following specialties:

  • 02.02 Epidemiology (medical and biological sciences)
  • 01.09 Infectious diseases
  • 03.07 Chemotherapy and antibiotics
  • 02.02 Virology (medical and biological sciences)
  • 02.03 Microbiology (medical and biological sciences)

The journal is presented in the following international bibliographic databases and information and reference systems: RSCI (on the platform WoS), Abstract Journals, AIDS & Cancer Research, Biocontrol News and Information, Biological Sciences, Chemical Abstracts, EBSCOhost Biological Abstracts, EBSCOhost Wildlife & Ecology Studies Worldwide, Elsevier BV Scopus, Elsevier BV EMBASE, Index Medicus, Excerpta Medica, Index Veterinarius, MEDLINE, National Library of Medicine PubMed, Parasitology Database, Poultry Abstracts, Review of Medical and Veterinary Entomology, Thomson Reuters Biological Abstracts, Thomson Reuters BIOSIS Previews, Thomson Reuters Science Citation Index Expanded, Thomson Reuters Web of Science, Tropical Diseases Bulletin, Veterinary Science Database, Virology and AIDS Abstracts, ROAD, DOAJ.

Content is available under license Creative Commons — Attribution 4.0 International, CC-BY.

Each article published in the journal is assigned a digital object identifier (DOI).

All articles, reviews and lectures published in the journal undergo mandatory double-blind peer review by members of the editorial board and invited experts.

Articles by foreign authors, as well as Russian-language articles separately recommended by the editorial board, are published in Russian and English under a single DOI. Native-language translation and its scientific editing is carried out at the expense of the Editorial Board.

The journal is registered with the Federal Service for Supervision of Communications, Information Technology and Mass Communications. Certificate PI No. FS77-77676.

The journal is published once every 2 months (6 issues per year).

The journal is a printed edition of the All-Russian public organization “The All-Russian Scientific and Practical Society of Epidemiologists, Microbiologists and Parasitologists”.

Founders:

  • FBIS Central Research Institute of Epidemiology of the Federal Service for Supervision of Consumer Rights Protection and Human Welfare,
  • All-Russian public organization "All-Russian Scientific and Practical Society of Epidemiologists, Microbiologists and Parasitologists".

Publisher:

  • FBIS Central Research Institute of Epidemiology of the Federal Service for Supervision of Consumer Rights Protection and Human Welfare.

When registering on the journal’s website readers and authors receive automatic notifications about the content of new issues of the Journal to their email address with the ability to unsubscribe from the newsletter.

Announcements More Announcements...

 
No announcements have been published.

Current Issue

Vol 70, No 2 (2025)

Cover Page

Full Issue

REVIEWS

Reassortant strains of Rotavirus A (Sedoreoviridae: Rotavirus: Rotavirus A): the role of animal rotaviruses in the emergence of new human rotavirus variants
Velikzhanina E.I., Sashina T.A., Novikova N.A.
Abstract

Animal rotaviruses (RV) play a significant role in the formation of new variants of epidemiologically significant human group A rotavirus (RVA) strains.A reassortant variant of genotype G3P[8] which has been shown to originate from RV in horses and cattle currently dominates on the territory of the Russian Federation. In addition, reassortant RV variants of genotypes G3P[3], G3P[9], G6P[9], similar to RV of cats and dogs, have been sporadically identified in the world for a long time. Given the relevance of this topic, a detailed study of the AU-1-like genetic group of RVAs, whose representatives are closely related to animal RVs, particularly those found in cats and dogs, is of scientific and practical interest.

The aim of this review is to analyze published scientific data on human, feline and canine RV that belong to the AU-1-like genetic group and have been studied based on their complete genotypes.

Problems of Virology. 2025;70(2):105-116
pages 105-116 views

ORIGINAL RESEARCH

Genetic diversity of Vif protein in human immunodeficiency virus type 1 variants (Retroviridae: Orthoretrovirinae: Lentivirus: Human immunodeficiency virus-1) that circulated in the Moscow region in 2019–2020
Antonova A.A., Protasova L.A., Kim K.V., Munchak I.M., Mezhenskaya E.N., Orlova-Morozova E.A., Pronin A.Y., Prilipov A.G., Kuznetsova A.I.
Abstract

Introduction. The Vif protein counteracts cellular deaminases, APOBEC3, which prevent viral replication. Vif is used for development of therapeutic agents. Natural polymorphisms in Vif can affect its functionality and may be associated with accelerated progression of HIV-infection to the AIDS. The study of Vif features in HIV-1 variants circulating in Russia has not been conducted previously.

The aim of the study: to study the genetic diversity of Vif in the HIV-1 variants that circulated in the Moscow region in 2019–2020.

Materials and methods. 234 whole blood samples obtained from HIV-infected patients without experience of therapy were analyzed. The study design included the following stages: extraction of proviral DNA, amplification of the vif gene, sequencing, identification of genetic variants, followed by a study of consensus sequences of the most common genetic variants of HIV-1, analysis of the conservation and genetic diversity of Vif-A6 (Vif protein of HIV-1 sub-subtype A6 variants) in patients with different stages of the disease, and assessment of genetic diversity of Vif-A6 in the Moscow region.

Results. A high degree of genetic diversity of vif gene was revealed. Consensus sequences of Vif in B and CRF63_02A6 variants were obtained for the first time. Characteristic substitutions in the consensus sequences were determined for the most common HIV-1 variants.

Conclusion. The limitation of this study is the small sample of B and CRF63_02A6. The results obtained may be of interest and may be taken into account in the development of therapeutic agents based on the Vif protein, as well as in the study of the pathogenicity of HIV-1 sub-subtype A6.

Problems of Virology. 2025;70(2):117-132
pages 117-132 views
Characteristics of the epidemic process of measles, rubella and mumps in Moscow and assessment of their seroprevalence at the present stage
Simakova Y.V., Gushchin V.A., Semenenko T.A., Ogarkova D.A., Kleymenov D.A., Nozdracheva A.V., Manuylov V.A., Tkachuk A.P., Gintsburg A.L.
Abstract

Introduction. The problem of vaccine-preventable infections requires assessing the state of herd immunity through serological monitoring.

The aim. To study the epidemiological features of measles, rubella and mumps and to estimate their seroprevalence in the last decade in Moscow.

Materials and methods. Forms of federal statistical observation; State reports «On the state of sanitary and epidemiological well-being of the Moscow population»; official EMISS data for 2012–2023 were used to conduct a retrospective analysis of incidence. Blood serum samples (n = 7458) from healthy individuals stratified by age were tested for the presence of IgG antobodies to measles, rubella and mumps using the ELISA. Statistical data processing was performed using Microsoft Excel and SPSS Statistics v.27 (IBM).

Results. The analysis of epidemiological situation in Moscow in 2012–2023 revealed the presence of multidirectional trends: wave-like increase in the incidence of measles, stabilization of rubella cases registration and unstable incidence of mumps with an upward trend. A high prevalence of IgG antibodies to rubella virus was determined, preventing the spread of infection among the population. The formed level of herd immunity to mumps does not allow reducing the incidence to sporadic cases. The observed trend of increasing measles incidence can be explained by the accumulation of non-immune individuals among the population.

Conclusion. The significant proportion of seronegative individuals indicate the necessity to adjust vaccination prevention tactics and implement measures for mopping-up and catch-up immunization of the population against measles and mumps, especially in risk age groups.

Problems of Virology. 2025;70(2):133-146
pages 133-146 views
Detection of the Liman tick virus (unclassified Chuviridae) in tick cell line HAE/CTVM8
Litov A.G., Shchetinin A.M., Kholodilov I.S., Belova O.A., Kalyanova А.S., Gushchin V.A., Karganova G.G.
Abstract

Introduction. Tick cell lines are widely used to study the biology of ticks and tick-borne pathogens, especially viruses. Most of the cell cultures currently available have been obtained from tick embryonic cells and can be infected with viruses. The HAE/CTVM8 cell line was obtained from Hyalomma anatolicum ticks and is often used for isolation of novel viruses.

The aim of the work is to study the HAE/CTVM8 cell line using high-throughput sequencing in order to search for viruses in it.

Materials and methods. The HAE/CTVM8 cell culture fluid was ultracentrifuged. The resulting pellet was used for high-throughput sequencing after RNA extraction, reverse transcription reaction, and synthesis of the second strand. The resulting reads were filtered by length and quality in the Trimmomatic program, after which the contigs were assembled using the SPAdes program and analyzed for the presence of viral sequences. The final assembly of the virus genome was carried out in the Ugene program. Sequence alignment was performed by the MAFFT program. The phylogenetic trees were constructed using the IQ-TREE program.

Results. We have identified the persistence of one virus, Liman tick virus (LMTV), in HAE/CTVM8 cell culture. Phylogenetically LMTV belongs to the Chuviridae – novel family, that consists of viruses detected by high-throughput sequencing, the virological characteristics of which are currently unknown.

Conclusion. The obtained information is of significant importance when utilizing HAE/CTVM8 cell culture in scientific research and during the process of isolating new viruses. Our study shows that this cell line with persistent LMTV is a ready-to-use system for studying Chuviridae reproduction

Problems of Virology. 2025;70(2):147-153
pages 147-153 views
The results of the detection of specific IgG antibodies to Ebola virus (Filoviridae: Orthoebolavirus) in residents of the Republic of Guinea after the end of the epidemic
Naidenova E.V., Kartashov M.Y., Shulgina I.S., Pyankov S.A., Kulagin M.A., Bah M.B., Nourdine I., N’Fally M., Konomou V., Traore M.S., Boumbaly S., Kutyrev V.V.
Abstract

Introduction. In 2014–2016, an epidemic of Ebola virus disease (EVD) was registered in Guinea. In 2021, EVD cases were repeated in the region. The importance of studying the duration of post-infection immunity to the Ebola virus in the body of convalescents is due to the fact that after the end of the epidemic they can be the main sources of infection. One of the indicators of the pathogen circulation in a certain area is the detection of specific IgG antibodies in the blood sera of the inhabitants.

The aim of the study is to identify IgG immunoglobulins to Ebola virus in the blood sera of reconvalescents and practically healthy residents of the Republic of Guinea after the end of the epidemic.

Materials and methods. The ELISA method was used to test the blood sera of 9 patients treated at the NKDCEM hospital (Kindia), collected after the end of the disease and up to 72 months after recovery, and 3939 blood serum samples from practically healthy residents of Guinea.

Results. IgG antibodies in the blood sera of reconvalescents a month after recovery were detected in a titer of up to 1 : 800. By 12 months, the antibody level decreased to 1 : 100 and remained at this level for up to 48 months. After 6 years of observation, no antibodies were registered. Among the 3939 blood samples from healthy residents, IgG immunoglobulins to the Ebola virus were detected in 5.6%. Most of the positive samples were collected in Forest Guinea (7.7%), and a smaller part in Upper Guinea (4.5%). The maximum percentage of positive samples was detected in people over 70 years of age (12.3%).

Conclusion. In our case, it was shown that a high level of post-infection immunity in the blood sera of patients with EVD persists for the first 6 months, this corresponds to the data obtained by other authors, and does not exclude the possibility of re-infection. The highest level of the seroprevalence is registered in Forest Guinea. This indicates the active circulation of the pathogen and the constant contact of the inhabitants of the region with it, which leads to epidemiological complications.

Problems of Virology. 2025;70(2):154-163
pages 154-163 views
Genetic diversity of human metapneumovirus (Pneumoviridae: Metapneumovirus) in Russia: results of molecular analysis
Fadeev A.V., Ivanov Y.V., Petrova P.A., Perederiy A.A., Pisareva M.M., Moshkin A.D., Komissarov A.B., Danilenko D.M., Lioznov D.A.
Abstract

Introduction. Human metapneumovirus (hMPV) holds significant epidemiological importance, being a dominant cause of lower respiratory tract infections in children under two years of age and individuals over 65. Multiple infections with hMPV throughout a person’s life are possible due to the antigenic and genetic variability of the virus. However, the genetic variability of hMPV circulating in Russia remains unexplored.

Aim of the study. The aim of this study was to test a protocol for whole-genome sequencing of hMPV to assess the genetic diversity of metapneumoviruses circulating in certain regions of Russia.

Materials and methods. Nasopharyngeal swabs were collected from patients of different ages with acute respiratory viral infections (ARVI) tested positive for hMPV using polymerase chain reaction (PCR). From some of the samples, viral isolates were obtained in cell culture. Whole-genome sequencing was performed on both swabs and isolates using the MiSeq Illumina platform, followed by phylogenetic analysis.

Results. For the first time in Russia, whole-genome sequencing of 44 hMPV strains circulating from 2017 to 2024 was conducted. Their genetic group affiliation was described, with the A2b2 clade shown to dominate. It was confirmed that the greatest variability among genes encoding viral surface proteins was observed in the G gene, while changes in the F gene were minimal during the studied period.

Conclusion. The study provides insights into the genetic diversity of hMPV strains circulating in various regions of the Russian Federation. Understanding the genetic variability of hMPV is crucial for comprehending viral evolution, transmission dynamics, and mechanisms of immune evasion, which influence the development of vaccines and antiviral drugs.

Problems of Virology. 2025;70(2):164-176
pages 164-176 views
Effect of inactivated whole-virion concentrated purified vaccine for the prevention of COVID-19 on clinical and biochemical blood parameters of immature rats
Siniugina A.A., Lycheva N.A., Saprykina A.A., Kryshen’ K.L., Apolokhov V.D., Chernavtseva A.D., Kovpak A.A., Ivin Y.Y., Piniaeva A.N., Makarova M.N., Makarov V.G., Ishmukhametov A.A.
Abstract

Introduction. The prevalence of new coronavirus infection (COVID-19) in 2021-2022 in the pediatric population was 9.5%, and fatal outcomes began to be recorded. In 2022–2023, the proportion of children infected with COVID-19 increased to 18%. Developing a vaccine for the pediatric population is an urgent task.

The aim of the study is to explore the effect of the vaccine on the parameters of general and biochemical blood tests in immature rats.

Materials and methods. The study was performed on 112 immature rats (60 females, 52 males) of the Wistar line. Animals were randomized into groups that received the CoviVac vaccine at doses of 0.125, 0.25 and 0.5 mL/animal or placebo (0.5 mL/animal), intramuscularly on days 1, 15, 29 and 43 of the experiment. General and biochemical blood tests were performed twice, on the 57th and 71st days.

Results. Oligocythemia (0.25 and 0.5 mL/animal, p < 0.05), leukocytosis and thrombocytopenia (0.5 mL/animal, p < 0.05) were recorded in males. Monocytopenia (0.5 mL/animal, p < 0.05) and leukopenia (0.25 mL/animal, p < 0.05) were established in females. In males, an increase in the amount of globulins and total protein (0.5 mL/animal), a decrease in the A/G ratio (doses 0.25 and 0.5 mL/animal), a decrease in the cholesterol level (0.125 mL/animal) were detected. In females, an increase in the amount of albumin and total protein (0.5 mL/animal, p < 0.05), a decrease in the level of triglycerides (0.125, 0.25, 0.5 mL/animal, placebo, p < 0.05), a decrease in the level of lactate dehydrogenase, triglycerides and urea (0.25 mL/animal, p < 0.05) were recorded.

Conclusion. The safety of the CociVac vaccine in relation to clinical and biochemical blood parameters has been demonstrated.

Problems of Virology. 2025;70(2):177-188
pages 177-188 views
Immunological properties of a chimeric protein containing the major capsid protein of echovirus 30 (Picornaviridae: Enterovirus: Enterovirus betacoxsackie)
Melentev D.A., Novikov D.V., Mokhonova E.V., Novikova N.A., Kashnikov A.Y., Selivanova S.G., Golitsyna L.N., Lapin V.A., Tsyganova M.I., Zaitsev D.E., Novikov V.V.
Abstract

Introduction. Enterovirus infection, widespread in the world and in Russia, is characterized by a variety of clinical forms, one of which is serous meningitis. The most common cause of enterovirus meningitis in children is echovirus 30 (E30). Previously, we obtained a chimeric protein consisting of the S domain of norovirus VP1 protein(SN), fused into one molecule with VP1 protein of E30 (SN-VP1E30), which in the future can be used to develop a vaccine for the prevention of enterovirus meningitis caused by the E30 virus.

The aim of this work was to study the immunological properties of the SN-VP1E30 protein.

Materials and methods. Balb/c mice and a guinea pig were immunized with the SN-VP1E30 protein. The production of IgG and IgM antibodies was studied by ELISA. The interaction of antibodies against SN-VP1E30 with virions of enteroviruses E30 of different genotypes was studied by electron microscopy. The reaction of neutralization of E30 by antibodies was carried out in vitro in RD cells.

Results. In mice immunized with SN-VP1E30 without adjuvant, the average titers of total antibodies against E30 VP1 protein were 1 : 19,000. The use of adjuvant increased the average titer of antibodies by 3 times. The level of IgM antibodies was significantly lower and amounted to, on average, 1 : 1500. Using immunoelectron microscopy, it was shown that guinea pig antibodies against chimeric SN-VP1E30 are able to bind virions of E30 genotypes h and eC2. Mouse and guinea pig antibodies were able to neutralize E30 in RD cell line. Neutralizing antibody titers in mice varied from 20 to 40, and were 40 in guinea pigs.

Conclusion. The immunogenicity of SN-VP1E30 in two animal species and the ability of antibodies to bind and neutralize enterovirus E30 allows us to propose it as an antigen in a vaccine for the prevention of diseases caused by E30.

Problems of Virology. 2025;70(2):189-198
pages 189-198 views


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies